HIMSS AsiaPac18 will Feature Best Practice from Global Militaries in the International Military Health Information Technology (IMHIT) Track

Food and Healthcare Press Releases Tuesday October 2, 2018 08:01
SINGAPORE--2 Oct--PRNewswire/InfoQuest
The HIMSS AsiaPac18 Conference and Exhibition will feature HIMSS' first-ever International Military Health Information Technology (IMHIT) track on 7 November.

"HIMSS has received tremendous support from global militaries that are embarking on their digital journey. IMHIT is our response to their call for education and knowledge sharing in a sector where point-of-care information is so critical to saving lives," said Simon Lin, Vice President, APAC.

From Genesis in the USA to the Singapore Armed Forces (SAF) Patient Care Enhancement System (PACES) 3 – the first SAF electronic medical record system to be connected to national healthcare systems – military organisations around the world are now fast-tracking their health IT investments.

The IMHIT program's morning panel discussion titled Health Information Exchange in Military Health Systems to Support Care Coordination Within and Across Borders will address how military health leaders are optimizing these systems to enable coordinated care and suggest areas for improvement and peer learning as they navigate IT within and across austere care environments.

The panel discussion will feature:
  • Air Vice-Marshal Alastair Reid, Defence Medical Director & HQ Surgeon General, Ministry of Defence, United Kingdom
  • Air Vice-Marshal Tracy Smart, Commander Joint Health & Surgeon General, Australian Defence Force, Australia
  • Lieutenant Colonel Lee Turner, Chief Nursing Officer and Director Health Business Performance, Defence Health Directorate, New Zealand Defence Force, New Zealand
  • Rear Admiral Dr. Tang Kong Choong, Chief of Medical Corps, Singapore Armed Forces, Singapore
The afternoon track will cover: country defence digital health strategies, challenges and opportunities for medical information in defence and clinical governance in military health.

"It is an immense privilege and honour, to be part of the inaugural IMHIT event. It is fitting that this prestigious event is occurring in Brisbane, which is home to some of the largest components of the Australian Defence Force deployable health capability. This is a very positive initiative organised by HIMSS and ADF Health Knowledge Management project staff, and it represents a strong and timely platform to discuss how innovation and technologies can drive change that enables a digital transition of healthcare models for global Defence requirements, including better access to care and improved care outcomes for our active service personnel and veterans," said AVM Tracy Smart, Commander Joint Health & Surgeon General, Australian Defence Force, Australia.

"The military environment is primed for digital disruption and it is an absolute pleasure to bring my international and military medicine experience to HIMSS AsiaPac18 and discuss possibilities at length with global military leaders," added Dr. Charles Alessi, Chief Clinical Officer, HIMSS & IMHIT moderator.

The IMHIT track program was jointly developed by HIMSS Asia Pacific and global military health leaders. View the program committee at https://www.himssasiapacconference.org/ehome/287692/742374/ .
Visit www.himssasiapacconference.org for more information.
Early bird promotion has been extended to 5 October.

Latest Press Release

BioNet reports on persistence of antibody responses of recombinant pertussis vaccines in the Lancet Infectious Diseases

Publications report the sustained higher antibody responses of BioNet acellular pertussis vaccines containing genetically inactivated pertussis toxin (PTgen) and the new opportunities to control the resurgence of whooping cough disease BioNet announced...

The Menarini Group Announces Meropenem/vaborbactam European Marketing Authorization

- Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections - The first combination of a carbapenem and a beta-lactamase inhibitor approved for clinical use in...

Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

- FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of first clinical data in BTC - BTC is a group of rare, aggressive...

Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities

- Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include...

Vitality-linked Insurers to Get 100 million People 20% More Active by 2025

Building on the results of the largest behaviour change study on physical activity, Vitality and its global network of insurers have collectively committed to improving the health of millions over the next seven years. This is in line with the World...

Related Topics